Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serine Combined with Fluorouracil in Advanced Colorectal Cancer
NCT07178613Phase 1Not yet recruiting
- Sponsor
- Xinxiang Medical University First Affiliated Hospital
- Start
- Nov 2025
- Primary completion
- Feb 2026
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label, single-arm trial of serine in colorectal cancer (CRC), sponsored by Xinxiang Medical University First Affiliated Hospital. Primary endpoint: Safety of Oral Serine up to 28 days. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
serine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07178613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07178613.